Nelson Laboratories strongly recommends that reusable medical device manufacturers reevaluate their validation testing procedures following a growing trend of increased scrutiny by the Food and Drug Administration (FDA) of the currently accepted validations for cleaning, disinfection and sterilization methods for their devices.
"It is clear the FDA is recommending increased testing procedures that more closely simulate the actual and clinical use of reusable medical devices, says Alpa Patel, department scientist for hospital reprocessing at Nelson Laboratories. As indicated by recent responses, the FDA would like manufacturers to perform testing on three runs for cleaning validations. This is a change from previous practices and is catching many manufacturers by surprise.
Specifically, the FDA would like to see validations performed in worst-case scenarios, which include:
Using clinically relevant soils.
Performing more runs of the validation.
Performing an exhaustive extraction to obtain extraction efficiency.
Performing end of use life testing.
Manufacturers will need to use test soils during validation that simulate actual use and are clinically relevant. The FDA is also requesting testing of worst-case dwell times the time between patient use and actual cleaning of a reusable device.
Additionally, the FDA is increasingly requiring cleaning validation analysis using a series of assays such as protein, hemoglobin, carbohydrate, endotoxin and total organic carbon. A focus on these markers is a change over the old process, which focused on bioload reduction. The FDA would also like to see manufacturers validate their devices using the labeled dose and time recommendation of the detergent used during cleaning.
Based on our experience with multiple companies who have received FDA responses requesting additional testing, manufacturers should become familiar with the recently published FDA draft guidance document, says Patel. Failure to do so may increase risk and delays in product launches.
Nelson Laboratories is a leading provider of full, life-cycle microbiology testing services.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.